[{"Assets_0_Q1_USD":6076100000.0,"CommonStockSharesConverted_0_Q1_shares":218500000.0,"CommonStockSharesOutstanding_0_Q1_shares":206500000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":207000000.0,"StockholdersEquity_0_Q1_USD":3901100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":211700000.0,"EarningsPerShareBasic_1_Q1_USD":1.49,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":208200000.0,"NetIncomeLossConverted_1_Q1_USD":310600000.0,"EarningsPerShareDiluted_1_Q1_USD":1.47,"RevenuesConverted_1_Q1_USD":1128700000.0,"Ticker":"EW","CIK":"1099800","name":"EDWARDS LIFESCIENCES CORP","OfficialName":"Edwards Lifesciences Corporation Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77366347639.0","Country":"United States","Sector":"Health Care","Industry":"Industrial Specialties","Market":"NYSE","SP500":"SP500","filed":"20200428"}]